252 related articles for article (PubMed ID: 31152916)
21. Tumor suppressor properties of the splicing regulatory factor RBM10.
Hernández J; Bechara E; Schlesinger D; Delgado J; Serrano L; Valcárcel J
RNA Biol; 2016; 13(4):466-72. PubMed ID: 26853560
[TBL] [Abstract][Full Text] [Related]
22. RBM5 as a putative tumor suppressor gene for lung cancer.
Sutherland LC; Wang K; Robinson AG
J Thorac Oncol; 2010 Mar; 5(3):294-8. PubMed ID: 20186023
[TBL] [Abstract][Full Text] [Related]
23. An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors.
Wang Y; Wang Y; Li K; Du Y; Cui K; Yu P; Zhang T; Liu H; Ma W
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33000861
[TBL] [Abstract][Full Text] [Related]
24. Intronic RNA: Ad'junk' mediator of post-transcriptional gene regulation.
Neil CR; Fairbrother WG
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194439. PubMed ID: 31682938
[TBL] [Abstract][Full Text] [Related]
25. Splicing in the pathogenesis, diagnosis and treatment of ciliopathies.
Wheway G; Lord J; Baralle D
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194433. PubMed ID: 31698098
[TBL] [Abstract][Full Text] [Related]
26. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
[TBL] [Abstract][Full Text] [Related]
27. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
28. Landscape of Alternative Splicing Events Related to Prognosis and Immune Infiltration in Glioma: A Data Analysis and Basic Verification.
Su HX; Yang G; Su F; Hu CX; Zhang T; Ran JT; Guan QL
J Immunol Res; 2022; 2022():2671891. PubMed ID: 35832652
[TBL] [Abstract][Full Text] [Related]
29. Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma.
Tremblay MP; Armero VE; Allaire A; Boudreault S; Martenon-Brodeur C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M
BMC Genomics; 2016 Aug; 17(1):683. PubMed ID: 27565572
[TBL] [Abstract][Full Text] [Related]
30. Identification of alternative splicing and lncRNA genes in pathogenesis of small cell lung cancer based on their RNA sequencing.
Lei Y; Shi Y; Duan J; Liu Y; Lv G; Shi R; Zhang F; Yang Q; Zhao W
Adv Clin Exp Med; 2019 Aug; 28(8):1043-1050. PubMed ID: 31403267
[TBL] [Abstract][Full Text] [Related]
31. Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.
Zhang L; Liu X; Zhang X; Chen R
Mol Genet Genomics; 2016 Jun; 291(3):1035-51. PubMed ID: 26711644
[TBL] [Abstract][Full Text] [Related]
32. Nuclear Aurora kinase A switches m
Li S; Qi Y; Yu J; Hao Y; He B; Zhang M; Dai Z; Jiang T; Li S; Huang F; Chen N; Wang J; Yang M; Liang D; An F; Zhao J; Fan W; Pan Y; Deng Z; Luo Y; Guo T; Peng F; Hou Z; Wang C; Zheng F; Xu L; Xu J; Wen Q; Jin B; Wang Y; Liu Q
Signal Transduct Target Ther; 2022 Apr; 7(1):97. PubMed ID: 35361747
[TBL] [Abstract][Full Text] [Related]
33. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.
Sveen A; Kilpinen S; Ruusulehto A; Lothe RA; Skotheim RI
Oncogene; 2016 May; 35(19):2413-27. PubMed ID: 26300000
[TBL] [Abstract][Full Text] [Related]
34. Co-regulated gene expression of splicing factors as drivers of cancer progression.
Koedoot E; Smid M; Foekens JA; Martens JWM; Le Dévédec SE; van de Water B
Sci Rep; 2019 Apr; 9(1):5484. PubMed ID: 30940821
[TBL] [Abstract][Full Text] [Related]
35. Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer.
Kędzierska H; Piekiełko-Witkowska A
Cancer Lett; 2017 Jun; 396():53-65. PubMed ID: 28315432
[TBL] [Abstract][Full Text] [Related]
36. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
37. Alternative splicing and cancer: a systematic review.
Zhang Y; Qian J; Gu C; Yang Y
Signal Transduct Target Ther; 2021 Feb; 6(1):78. PubMed ID: 33623018
[TBL] [Abstract][Full Text] [Related]
38. Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks.
Sebestyén E; Singh B; Miñana B; Pagès A; Mateo F; Pujana MA; Valcárcel J; Eyras E
Genome Res; 2016 Jun; 26(6):732-44. PubMed ID: 27197215
[TBL] [Abstract][Full Text] [Related]
39. Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data.
Feng H; Li T; Zhang X
BMC Genomics; 2018 Aug; 19(Suppl 6):564. PubMed ID: 30367578
[TBL] [Abstract][Full Text] [Related]
40. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]